“The essence of our culture is built on meeting global standards in every aspect of our business.” Morksons Pharmaceutical india pvt ltd., headquartered at Roorkee (India) is a global pharmaceutical company. We are actively engaged in R&D and offer CRAMS to global pharmaceutical companies. OUR FOCUS Our key focus areas lie in the OTC & prescription drugs that have wide-ranging appliactions across fields like Oncology, Gastroenterology, Antidiabetic, Antibiotics, Cardiovascular, Pain Management, Gynaecology, among others. OUR STRENGTH We are establishing world-class manufacturing facilities by leveraging state-of-the-art technology, incorporating best practices and adhering to stringent regulatory compliances. Our plants are approved by prestigious US FDA, UK MHRA, Australian TGA and other foreign health authorities. Our R&D capabilities include dossier development, chemical synthesis, process optimization, formulation development, analytical development and conducting stability studies. We have a team of over 50 experienced scientists specializing in formulation development and analytical development. We possess end-to-end capabilities – from Lab scale development to Pilot scale up and from commercializing the product for large scale manufacturing to marketing globally. The company has achieved global recognition within a very short span of time and has major global expansion plans for the near future.

“The essence of our culture is built on meeting global standards in every aspect of our business.” Morksons Pharmaceutical india pvt ltd., headquartered at Roorkee (India) is a global pharmaceutical company. We are actively engaged in R&D and offer CRAMS to global pharmaceutical companies. OUR FOCUS Our key focus areas lie in the OTC & prescription drugs that have wide-ranging appliactions across fields like Oncology, Gastroenterology, Antidiabetic, Antibiotics, Cardiovascular, Pain Management, Gynaecology, among others. OUR STRENGTH We are establishing world-class manufacturing facilities by leveraging state-of-the-art technology, incorporating best practices and adhering to stringent regulatory compliances. Our plants are approved by prestigious US FDA, UK MHRA, Australian TGA and other foreign health authorities. Our R&D capabilities include dossier development, chemical synthesis, process optimization, formulation development, analytical development and conducting stability studies. We have a team of over 50 experienced scientists specializing in formulation development and analytical development. We possess end-to-end capabilities – from Lab scale development to Pilot scale up and from commercializing the product for large scale manufacturing to marketing globally. The company has achieved global recognition within a very short span of time and has major global expansion plans for the near future.